Published on: June 28, 2017 at 12:00PM Condition: Pancreatic Neuroendocrine TumorInterventions: Drug: Tegafur and Temozolomide; Drug: Tegafur and Temozolomide combined with ThalidomideSponsor:...
cancer
Published on: June 28, 2017 at 12:00PM Condition: Malignant Neoplasms of Urinary TractInterventions: Drug: Pro-Stat Sugar-free AWC; Dietary Supplement: Omega-3 Fatty AcidsSponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)Not yet recruiting...
Published on: June 25, 2017 at 12:00PM Condition: Breast NeoplasmsIntervention: Drug: FulvestrantSponsor: Fudan UniversityNot yet recruiting - verified June 2017...
Published on: June 25, 2017 at 12:00PM Condition: Breast NeoplasmsIntervention: Drug: FulvestrantSponsor: Fudan UniversityNot yet recruiting - verified June 2017...
Published on: June 25, 2017 at 12:00PM Condition: Breast NeoplasmsIntervention: Drug: FulvestrantSponsor: Fudan UniversityNot yet recruiting - verified June 2017...
Published on: June 25, 2017 at 12:00PM Condition: Breast NeoplasmsIntervention: Drug: FulvestrantSponsor: Fudan UniversityNot yet recruiting - verified June 2017...
Published on: June 25, 2017 at 12:00PM Condition: Breast NeoplasmsIntervention: Drug: FulvestrantSponsor: Fudan UniversityNot yet recruiting - verified June 2017...
Published on: June 28, 2017 at 12:00PM Condition: Advanced CancerInterventions: Biological: Lirilumab; Biological: Nivolumab; Biological: IpilimumabSponsors: Bristol-Myers Squibb; Ono PharmaceuticalsNot...
Published on: June 23, 2017 at 12:00PM Condition: Ovarian CancerIntervention: Sponsor: AstraZenecaNot yet recruiting - verified June 2017...
Published on: June 23, 2017 at 12:00PM Condition: Ovarian CancerIntervention: Sponsor: AstraZenecaNot yet recruiting - verified June 2017...
Published on: June 23, 2017 at 12:00PM Condition: Ovarian CancerIntervention: Sponsor: AstraZenecaNot yet recruiting - verified June 2017...
Published on: June 27, 2017 at 12:00PM Condition: Malignant Neoplasm of BreastInterventions: Drug: Cobimetinib; Drug: Atezolizumab; Drug: EribulinSponsors: M.D. Anderson Cancer Center; Genentech, Inc.Not...
Published on: June 27, 2017 at 12:00PM Condition: Malignant Neoplasm of BreastInterventions: Drug: Cobimetinib; Drug: Atezolizumab; Drug: EribulinSponsors: M.D. Anderson Cancer Center; Genentech, Inc.Not...
Published on: June 27, 2017 at 12:00PM Conditions: Non-Resectable Cholangiocarcinoma; Recurrent CholangiocarcinomaInterventions: Drug: Atezolizumab; Drug: Cobimetinib; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Not...
Published on: June 23, 2017 at 12:00PM Condition: Metastatic ER+ Breast CancerIntervention: Drug: TTC-352Sponsor: TTC Oncology, LLCNot yet recruiting - verified June 2017...
Published on: June 26, 2017 at 12:00PM Conditions: Breast Neoplasm; LesionInterventions: Device: Implanted Medical Device; Procedure: Mammography; Other: Questionnaire Administration; Procedure: Radiofrequency-Guided Localization;...
Published on: June 25, 2017 at 12:00PM Conditions: Lung Cancer; Non Small Cell Lung Cancer; Combination Chemotherapy; ApatinibInterventions: Drug: Apatinib; Drug: AP or AC;...
Published on: June 25, 2017 at 12:00PM Conditions: Lung Cancer; Non Small Cell Lung Cancer; Combination Chemotherapy; ApatinibInterventions: Drug: Apatinib; Drug: AP or AC;...
